Crossing the Blood-Brain Barrier: Advances in Dendrimer-Based Nanocarriers for Central Nervous System Delivery

Key Points

Dendrimer-based nanocarriers effectively cross the blood-brain barrier, offering new possibilities for treatment.
Their application shows significant potential in addressing challenges posed by CNS disorders and delivery methods.
Innovations in dendrimer technology may lead to improved treatment and diagnostic approaches for neurological conditions.
Utilizing dendrimers could revolutionize how medications are administered across the blood-brain barrier for CNS therapies.

Abstract

Dendrimer-based nanocarriers are emerging as transformative platforms to overcome the challenge of crossing the blood-brain barrier (BBB) in the treatment and diagnosis of central nervous system (CNS) disorders. Their highly...

Crossing the Blood-Brain Barrier: Advances in Dendrimer-Based Nanocarriers for Central Nervous System Delivery

Key Points

Abstract

Cite This Study